Andere Sprachen LifeStance Health Group, Inc.

Aktien

A3CS0T

US53228F1012

LFST

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:24:07 01.05.2024			% 5 Tage	% 1. Jan.
6,325 ^USD	+2,35 %		+2,35 %	-19,35 %

12.03.	LifeStance Health ernennt Teresa DeLuca zum Mitglied des Vorstands	CI
07.03.	LIFESTANCE HEALTH GROUP, INC. : Bewertung von Jefferies & Co. zum Kaufen erhalten	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

LifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica Ambassadors	15:01
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024	18.04.
LifeStance Appoints Dr. Teresa DeLuca to Board of Directors	12.03.
LifeStance Health Appoints Teresa DeLuca to Its Board of Directors	12.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	12.03.
Lifestance Health Group Insider Sold Shares Worth $923,391, According to a Recent SEC Filing	05.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	03.03.
Sector Update: Health Care Stocks Decline Late Afternoon	28.02.
Sector Update: Health Care Stocks Softer Wednesday Afternoon	28.02.
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	28.02.
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	28.02.
LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
LifeStance Health Group, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024	28.02.
LifeStance Reports Fourth Quarter and Full Year 2023 Results	28.02.
LifeStance Health Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	24.02.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	16.02.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	08.02.
LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024	07.02.
Sector Update: Health Care Stocks Rise in Late Afternoon	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen LifeStance Health Group, Inc.

Aktien

A3CS0T

US53228F1012

LFST

Andere Sprachen

Filter